Literature DB >> 19150644

Multiple challenges in a mouse model of chemical-induced asthma lead to tolerance: ventilatory and inflammatory responses are blunted, immunologic humoral responses are not.

Jeroen A J Vanoirbeek1, Vanessa De Vooght, Benoit Nemery, Peter H M Hoet.   

Abstract

To improve our mouse model of chemical-induced asthma we compared a single with a multiple intranasal challenge protocol. BALB/c mice received toluene diisocyanate (TDI) or vehicle on each ear (days 1 and 8) with the first challenge by intranasal instillation given on day 15. In a "long" protocol, the mice received 1 to 6 intranasal instillations, with 1-week interval. In a "short" protocol, the mice received 6 intranasal challenges over a period of 10 days. The "early" ventilatory response and methacholine reactivity were measured. Broncho-alveolar-lavage (BAL), total serum immunoglobulins and draining lymph nodes were analyzed. After 1, 2 or 3 TDI challenges, a significant increase in airway reactivity, total cell count and neutrophils (15-20%) was found in TDI-treated mice. This response diminished with increasing numbers of challenges in both models. The percentage CD4(+) and CD8(+) cells decreased and the percentage CD19(+) cells increased in the lymph nodes, but these returned to control values with multiple challenges. IL-4 secretion increased in cervical lymph node cells in vitro. Total serum IgE levels were persistently increased in TDI-treated mice. Although humoral signs of allergy remain increased after multiple challenges, diminishing ventilatory and inflammatory responses are indicative of the induction of tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19150644     DOI: 10.1016/j.tox.2008.12.020

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

1.  Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma.

Authors:  Vanessa De Vooght; Jeroen A J Vanoirbeek; Katrien Luyts; Steven Haenen; Benoit Nemery; Peter H M Hoet
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

2.  Clinical efficacy of recombinant human latrophilin 3 antibody in the treatment of pediatric asthma.

Authors:  Maohua Liu; Jingxiu Zhang; Chengjun Liu
Journal:  Exp Ther Med       Date:  2017-10-25       Impact factor: 2.447

3.  Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses.

Authors:  Adam V Wisnewski; Lan Xu; Eve Robinson; Jian Liu; Carrie A Redlich; Christina A Herrick
Journal:  J Occup Med Toxicol       Date:  2011-03-17       Impact factor: 2.646

4.  Re-challenge with ovalbumin failed to induce bronchial asthma in mice with eosinophilic bronchitis.

Authors:  Liyan Chen; Nanshan Zhong; Kefang Lai
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  Vitamin E effect in a rat model of toluene diisocyanate-induced asthma.

Authors:  Andrea Daniela Muti; Alina Elena Pârvu; Leon Adrian Muti; Remus Moldovan; Adriana Mureşan
Journal:  Clujul Med       Date:  2016-10-20

6.  IL-4 and IL-5 secretions predominate in the airways of wistar rats exposed to toluene diisocyanate vapor.

Authors:  Kouame Kouadio; Kui-Cheng Zheng; Abdoulaye Abba Toure; Mireille Dosso; Hidemi Todoriki
Journal:  J Prev Med Public Health       Date:  2014-01-29

7.  B-lymphocytes as key players in chemical-induced asthma.

Authors:  Vanessa De Vooght; Vincent Carlier; Fien C Devos; Steven Haenen; Erik Verbeken; Benoit Nemery; Peter H M Hoet; Jeroen A J Vanoirbeek
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 8.  Toluene diisocyanate (TDI) airway effects and dose-responses in different animal models.

Authors:  Thomas Schupp; Michael A Collins
Journal:  EXCLI J       Date:  2012-07-24       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.